PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026Asian Pacific Journal of Cancer Prevention0 citationsOpen Access

Improved Overall Survival Due to Reduced Waiting Time in Nasopharyngeal Cancer Patients Treated with Chemoradiotherapy in Yogyakarta, Indonesia

View Full Paper
JDJudi Nani Annet DiessenEEEricko EkaputraBTBing Tan

Key Points

  • This research aims to assess how reduced waiting time affects overall survival in nasopharyngeal cancer patients undergoing chemoradiotherapy.
  • Analyzed patient outcomes at Dr. Sardjito Hospital
  • Compared waiting time and overall survival between years
  • Considered factors like staging methods and distant metastases
  • Waiting time decreased by 97 days compared to 2018
  • Overall survival rate after 2 years was 60.5%
  • Underestimation of distant metastases due to limited imaging availability

Abstract

In conclusion, this study analyzed the impact of WT and OTT on outcomes for NPC patients undergoing chemoradiotherapy at Dr. Sardjito Hospital. A significant decrease in WT of 97 days was observed when compared to 2018. However, the limited availability of advanced imaging likely resulted in an underestimation of distant metastases, leading to a 2-yr OS of 60.5%. Better staging methods, as well as improved awareness of NPC, are crucial for better treatment decisions and improving future patient outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Diessen et al. (2026) studied this question.

synapsesocial.com/papers/6974610cbb9d90c67120af46https://doi.org/10.31557/apjcp.2026.27.1.201
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epidemiological Characteristics and 3-year Overall Survival Outcome of Nasopharyngeal Cancer in Central Java: A Single Institution Retrospective Study2024
  2. 2Real-world outcomes of nasopharyngeal carcinoma in a 20-year retrospective cohort from a lower-middle income country.2026
  3. 3Short-term OS as a surrogate endpoint for 5-year OS in nasopharyngeal carcinoma in non-endemic area2024
  4. 4Multimodal treatment according to the <scp>NPC</scp>‐<scp>GPOH</scp> trials in adult patients with nasopharyngeal cancer—Analysis based on a single‐center experience2024 · 1 citations
  5. 5New insights into the treatment of nasopharyngeal carcinoma in children, adolescents, and young adults: a retrospective study2026